Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Revenue

In the year 2025, Gyre Therapeutics had annual revenue of $116.59M with 10.24% growth. Gyre Therapeutics had revenue of $37.20M in the quarter ending December 31, 2025, with 33.45% growth.

• Revenue (ttm): $116.59M
• Revenue Growth: +10.24%
• P/S Ratio: 6.28
• Revenue / Employee: $201,361
• Employees: 579
• Market Cap: 732.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	116.59M	10.83M	10.24%
Dec 31, 2024	105.76M	-7.69M	-6.78%
Dec 31, 2023	113.45M	11.16M	10.91%
Dec 31, 2022	102.29M	94.95M	1,293.98%
Dec 31, 2021	7.34M	-34.56M	-82.49%
Dec 31, 2020	41.90M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	6.00K	-1.01M	-99.41%
Dec 31, 2017	1.02M	619.00K	155.14%
Dec 31, 2016	399.00K	-1.35M	-77.20%
Dec 31, 2015	1.75M	-63.00K	-3.47%
Dec 31, 2014	1.81M	1.29M	246.65%
Dec 31, 2013	523.00K	-115.20M	-99.55%
Dec 31, 2012	115.72M	-79.55M	-40.74%
Dec 31, 2011	195.27M	23.85M	13.91%
Dec 31, 2010	171.43M	121.30M	242.00%
Dec 31, 2009	50.12M	9.95M	24.78%
Dec 31, 2008	40.17M	17.02M	73.51%
Dec 31, 2007	23.15M	-31.92M	-57.96%
Dec 31, 2006	55.07M	52.71M	2,233.81%
Dec 31, 2005	2.36M	-	-